Comparative Study of Survival following Videothoracoscopic Lobectomy Procedures for Lung Cancer: Single- versus Multiple-port Approaches

医学 肺癌 端口(电路理论) 阶段(地层学) 外科 存活率 化疗 病态的 多元分析 肿瘤科 内科学 心胸外科 古生物学 生物 工程类 电气工程
作者
J.M. Borró,F. Regueiro,Sónia Pértega-Díaz,Manuel Constenla,Salvador Pita
出处
期刊:Archivos De Bronconeumologia [Elsevier BV]
卷期号:53 (4): 199-205 被引量:14
标识
DOI:10.1016/j.arbr.2016.08.004
摘要

Abstract Introduction Video-assisted thoracoscopic surgery has become the technique of choice in the early stages of lung cancer in many centers although there is no evidence that all of the surgical approaches achieve the same long-term survival. Method We carried out a retrospective review of 276 VATS lobectomies performed in our department, analyzing age, sex, comorbidities, current smoker, FEV1 and FCV, surgical approach, TNM and pathological stage, histologic type, neoadjuvant or coadjuvant chemotherapy, relapse and metastasis time, with the main aim of evaluating the survival rate and disease-free time, especially with regard to the two/three versus single port approach. Result The one/four year global survival rate was 88.1% and 67.6% respectively. Bivariate analysis found that the variables associated with survival are comorbidity, histological type, stage, surgical approach and need for chemotherapy. When we independently analyzed the surgical approach, we found a lower survival rate in the single-port group vs the two/three-port group (VATS). Stratifying by tumoral stage (stage I) and by tumor size (T2) survival was significantly lower for patients with single-port group in comparison to VATS approach. In the multivariate analysis, single-port group is associated with a higher risk of death (HR=1.78). In analyzing disease-free survival, differences were found in both cases in favor of two/three port VATS: P =.093 for local relapses and P =.091 for the development of metastasis. Conclusions These results challenge the use of the single port technique in malignant lung pathologies, suggesting the need for clinical trials in order to identify the role this technique may have in lung cancer surgery.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
迪仔完成签到 ,获得积分10
1秒前
青菜完成签到 ,获得积分10
1秒前
默成应助畅快小霸王采纳,获得10
3秒前
欣喜的高烽完成签到,获得积分10
4秒前
xxxxxxxxxx完成签到 ,获得积分10
4秒前
开心德天完成签到,获得积分10
8秒前
Tonald Yang完成签到 ,获得积分20
8秒前
9秒前
9秒前
keyan完成签到,获得积分10
10秒前
HuangShuting完成签到,获得积分10
10秒前
10秒前
郭小逗完成签到 ,获得积分10
11秒前
li完成签到 ,获得积分10
12秒前
为你等候完成签到,获得积分10
13秒前
少7一点8发布了新的文献求助10
14秒前
感动傲南完成签到,获得积分10
14秒前
乐观谷芹完成签到,获得积分10
16秒前
run完成签到 ,获得积分10
16秒前
16秒前
老实幻姬完成签到,获得积分10
16秒前
好困发布了新的文献求助10
18秒前
18秒前
111完成签到,获得积分10
19秒前
CodeCraft应助科研通管家采纳,获得10
20秒前
李爱国应助科研通管家采纳,获得10
20秒前
雪白访风完成签到,获得积分10
22秒前
咕噜噜完成签到 ,获得积分10
22秒前
jia发布了新的文献求助10
23秒前
逢场作戱__完成签到 ,获得积分10
23秒前
气煞我也完成签到 ,获得积分10
24秒前
pingbaby完成签到 ,获得积分10
24秒前
MHY完成签到,获得积分10
26秒前
淡定无施完成签到,获得积分10
26秒前
dan完成签到 ,获得积分10
28秒前
昵称完成签到 ,获得积分10
29秒前
健康的大门完成签到,获得积分10
29秒前
31秒前
jia完成签到,获得积分10
32秒前
徐慕源完成签到,获得积分10
32秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 800
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
CLSI VET01S-2024 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals (7th Ed) 500
DIPPR Project 801 - Full Version 380
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7765973
求助须知:如何正确求助?哪些是违规求助? 9309914
关于积分的说明 20313137
捐赠科研通 7350746
什么是DOI,文献DOI怎么找? 3315010
关于科研通互助平台的介绍 2464526
邀请新用户注册赠送积分活动 2329570